Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals
- 1.4k Downloads
Potentially inappropriate prescribing is common in older people presenting to hospital with acute illness in Ireland. The aim of this study was to determine if this phenomenon is unique to Ireland or whether it is a more widespread problem in hospitals across Europe.
Prospective data were collected from 900 consecutive older patients admitted to six university teaching hospitals (150 patients per centre) in Geneva (Switzerland), Madrid (Spain), Oostende (Belgium), Perugia (Italy), Prague (Czech Republic) and Cork (Ireland). Age, gender, comorbidity, cognitive status, prescription medicines taken before admission and baseline haematological, biochemical and electrocardiographic data were recorded. STOPP and Beers’ criteria were applied to detect potentially inappropriate medicines (PIMs). START criteria were applied to detect potentially inappropriate prescribing omissions (PPOs).
The overall PIM prevalence rate was 51.3% using STOPP criteria, varying from 34.7% in Prague to 77.3% in Geneva, and 30.4% using Beer’s criteria, varying from 22.7% in Prague to 43.3% in Geneva. Using START criteria, the overall PPO prevalence rate was 59.4%, ranging from 51.3% in Cork to 72.7% in Perugia. Polypharmacy predicted the presence of PIMs using STOPP criteria [with >10 medications: odds ratio (OR) 7.22, 95% confidence interval (CI) 4.30–12.12, p < 0.001] and Beers’ criteria (with >10 medications: OR 4.87, 95% CI 3.00–7.90, p < 0.001). Increasing co-morbidity (Charlson Index ≥2) and age ≥85 years significantly predicted PPOs.
Potentially inappropriate drug prescribing and the omission of beneficial drugs are highly prevalent in acutely ill hospitalized older people in six European centres.
KeywordsInappropriate prescribing Elderly STOPP/START Beers’ criteria
The Health Research Board of Ireland (Clinical Research Training Fellowship CRT/2006/029) and the Czech Ministry of Health Internal Grant Agency (NS/10029-4/2008) provided financial support for this study.
- 5.Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 44 (6): 957–963. doi: 10.1345/aph.1M657
- 11.McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 156(3):385–391Google Scholar
- 17.Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, Francis SD, Branch LG, Lindblad CI, Artz M, Weinberger M, Feussner JR, Cohen HJ (2004) Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116(6):394–401. doi: 10.1016/j.amjmed.2003.10.031S0002934303007526 PubMedCrossRefGoogle Scholar
- 19.Lau DT, Kasper JD, Potter DE, Lyles A (2004) Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res 39(5):1257–1276. doi: 10.1111/j.1475-6773.2004.00289.xHESR289 PubMedCrossRefGoogle Scholar
- 21.Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348–1358. doi: 10.1001/jama.293.11.1348 PubMedCrossRefGoogle Scholar
- 22.van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC (2005) Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria–a population-based cohort study. Br J Clin Pharmacol 60(2):137–144. doi: 10.1111/j.1365-2125.2005.02391.x PubMedCrossRefGoogle Scholar
- 24.Barry PJ, O'Keefe N, O'Connor KA, O'Mahony D (2006) Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 31(6):617–626. doi: 10.1111/j.1365-2710.2006.00783.x PubMedCrossRefGoogle Scholar
- 27.Topinkova E, Madlova P, Fialova D, Klan J (2008) New evidence-based criteria for evaluating the appropriateness of drug regimen in seniors. Criteria STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Vnitr Lék 54(12):1161–1169PubMedGoogle Scholar
- 30.Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, Cruz-Jentoft A, Montero B, Lang PO, Michel JP, O'Mahony D (2009) Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 38(5):603–606. doi: 10.1093/ageing/afp058 PubMedCrossRefGoogle Scholar
- 35.Corsonello A, Pedone C, Lattanzio F, Lucchetti M, Garasto S, Di Muzio M, Giunta S, Onder G, Di Iorio A, Volpato S, Corica F, Mussi C, Antonelli Incalzi R (2009) Potentially Inappropriate Medications and Functional Decline in Elderly Hospitalized Patients. J Am Geriatr Soc 57(6):1007–1014. doi: 10.1111/j.1532-5415.2009.02266.x PubMedCrossRefGoogle Scholar
- 36.Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493–503. doi: 10.1016/S0140-6736(07)61233-1 PubMedCrossRefGoogle Scholar
- 38.Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, Krumholz HM (2004) National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 110(6):724–731. doi: 10.1161/01.CIR.0000138934.28340.ED PubMedCrossRefGoogle Scholar